21 CFR Subpart B - Subpart B—Specific Sector Provisions for Medical Devices
- § 26.31 Purpose.
- § 26.32 Scope.
- § 26.33 Product coverage.
- § 26.34 Regulatory authorities.
- § 26.35 Length and purpose of transition period.
- § 26.36 Listing of CAB's.
- § 26.37 Confidence building activities.
- § 26.38 Other transition period activities.
- § 26.39 Equivalence assessment.
- § 26.40 Start of the operational period.
- § 26.41 Exchange and endorsement of quality system evaluation reports.
- § 26.42 Exchange and endorsement of product evaluation reports.
- § 26.43 Transmission of quality system evaluation reports.
- § 26.44 Transmission of product evaluation reports.
- § 26.45 Monitoring continued equivalence.
- § 26.46 Listing of additional CAB's.
- § 26.47 Role and composition of the Joint Sectoral Committee.
- § 26.48 Harmonization.
- § 26.49 Regulatory cooperation.
- § 26.50 Alert system and exchange of postmarket vigilance reports.
- Appendix A to Subpart B of Part 26—Relevant Legislation, Regulations, and Procedures.
- Appendix B to Subpart B of Part 26—Scope of Product Coverage
- Appendixes C–F to Subpart B of Part 26 [Reserved]